Galera Therapeutics Prices 4M Share IPO @$12/Share

Galera Therapeutics, Inc.

Benzinga · 11/07/2019 08:28

Galera Therapeutics, Inc. (NASDAQ: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $12.00 per share, for total gross proceeds of $60.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Galera. All of the common stock is being offered by Galera. In addition, Galera has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock at the initial public offering price less the underwriting discounts and commissions. Galera's common stock is expected to begin trading on the Nasdaq Global Market on November 7, 2019, under the ticker symbol "GRTX." The offering is expected to close on November 12, 2019, subject to customary closing conditions.

BofA Securities, Citigroup and Credit Suisse are acting as joint book-running managers for the offering and BTIG is acting as co-manager for the offering.